BBOT 8-K 2026-09-08

BridgeBio Oncology Therapeutics, Inc. (BBOT) 8-K dated 2026-09-08 — accession 0001193125-26-385225. This URL is the filing, not the BBOT hub.

BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.

BridgeBio Oncology Therapeutics, Inc. filed a 8-K on 2026-09-08. Accession 0001193125-26-385225.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BBOT revenue for 2026-06-30 was $7.5M. Net income was -$98.6M. Revenue was up 90.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.

Not investment advice. The BBOT SEC hub lists recent forms. The stock page is the research view.